Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VITAMIN E LEVEL EVALUATION IN PERIPHERAL NEUROPATHY PATIENTS

This article was originally published in The Tan Sheet

Executive Summary

VITAMIN E LEVEL EVALUATION IN PERIPHERAL NEUROPATHY PATIENTS with no known cause for the condition was recommended by Maret Traber, PhD, University of California at Berkeley, at the American Dietetic Association annual meeting in Orlando, Fla. on Oct. 18. Traber suggested that people with no known cause of peripheral neuropathy "may be the same kinds of patients" in terms of their ability to retain vitamin E as those with Friedreich's ataxia, a hereditary degenerative disease that has been associated with low plasma vitamin E levels.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083411

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel